BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL)

Lobbying client · District of Columbia · filed 2025 to 2026

$520,000 Reported spend

7 Filings counted

1 Outside firm hired

13 Bills named

Spend is reported income plus in-house expenses across 7 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. Everything on this page comes from one LDA client record (181280), filed by the registrant listed below.

Who filed for this client 1

TARPLIN, DOWNS & YOUNG, LLC $520,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 13

H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

3 filings
H.R. 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

3 filings
H.R. 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…

3 filings
H.R. 5461
Special Diabetes Program Reauthorization Act of 2025

3 filings
H.R. 5488
Special Diabetes Program for Indians Reauthorization Act of 2025

3 filings
S. 2211
Special Diabetes Program Reauthorization Act of 2025

3 filings
S. 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

3 filings
S. 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

3 filings
H.R. 8018
ISLET Act

1 filing
H.R. 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

1 filing
H.R. 9000
SCREEN for Type 1 Diabetes Act of 2026

1 filing
H.R. 9620
Military Next-Gen Collision Avoidance Act of 2026

1 filing
S. 4612
SCREEN for Type 1 Diabetes Act of 2026

1 filing

Reported by year 2 years

2026 $200,000 3 filings
2025 $320,000 4 filings

Issues lobbied 2

Budget/Appropriations 7
Health Issues 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Food & Drug Administration (FDA) 7
Health & Human Services, Dept of (HHS) 7
HOUSE OF REPRESENTATIVES 7
SENATE 7

Recent filings 8 total

Q3 report

TARPLIN, DOWNS & YOUNG, LLC

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026

View → Q3 report

TARPLIN, DOWNS & YOUNG, LLC Amended

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026

View → Q2 report

TARPLIN, DOWNS & YOUNG, LLC

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026

View → Q1 report

TARPLIN, DOWNS & YOUNG, LLC

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026

View → Q4 report

TARPLIN, DOWNS & YOUNG, LLC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 20, 2026

View → Q3 report

TARPLIN, DOWNS & YOUNG, LLC

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 16, 2025

View → Q2 report

TARPLIN, DOWNS & YOUNG, LLC

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 17, 2025

View → Q1 report

TARPLIN, DOWNS & YOUNG, LLC

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 21, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.